Noteworthy, both studies addressed the modulation of tumor cell's ligands interacting with microglia, but did not examine additional direct effects of R‐2‐HG on TAMs themselves, which might provide more insights into the immune function of TAMs in the TME of IDH‐mutant gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.